Monthly Archives September 2008

Rapid Growth in Asia-Pacific Spine Surgery Technology Markets

Overview of the Asia-Pacific (Japan, Australia, Korea) market for spine surgery technologies. Drawn from the MedMarket Diligence report #M510, described at http://mediligence.com/rpt/rpt-m510.htm.

Radiofrequency Ablation Markets by Country Worldwide, 2007-2017

Growth in the use of radiofrequency ablation technologies will expand worldwide as it is adopted for use in a wide range of clinical applications spanning cardiology, orthopedics, gynecology, general surgery and others. Below is illustrated the worldwide market growth of RF ablation.  
 
Data is drawn from “Worldwide Ablation Technologies 2007-2017, published September 2008, [...]

Technologies at new medtech companies (startups)

New medical technologies represented in specific companies recently added (September 2008) to the Medtech Startups Database:

Recombinant proteins and cells for intervertebral disc cell regeneration
Non-hydrogel polymer used to stimulate tissue growth in dental/orthopedic applications
Biomaterials and biologics for repair of bone and cartilage
Portable endoscopic imaging
Device treatments for restless leg syndrome (RLS)
Disposable steerable surgical instrumentation for arthroscopy
Technologies to [...]

Ablation Technologies Market Worldwide, by Region and Technology

 
The worldwide high energy therapies market represents a $25 billion opportunity in 2008.  The category consists of therapeutic devices and equipment that deliver the controlled application of one or more modalities of energy to tissue.
This market will grow at a compound annual growth rate of 11% with some modalities exceeding a 20% CAGR.
The global market [...]

Ablation Technologies in Treatment of Atrial Fibrillation

(From “Ablation Technologies Worldwide Market, 2008-2017:  Products, Technologies Markets, Companies and Opportunities.”  Published 2008 by MedMarket Diligence, LLC. See link.)
Several types of energy-based therapies have a variety of applications to CV disease—the number one killer in most of the world.
When the heart has to work too hard to maintain adequate blood output, it can begin [...]

Economy catches up with biotech investing (no surprise)

If you simply compare the average development times of pharmaceuticals, biotech and medical devices, you will see that medical devices demonstrate the shortest time from conception to market (or rejection). Devices, by virtue of providing, in many cases, a simple mechanical function — flatten atherosclerotic plaque against the lumen (angioplasty), keep it there (stents), close [...]